Anthony Michael D'urso, - Pharmacist in Framingham, MA

Anthony Michael D'urso, is a Pharmacist based in Framingham, Massachusetts. Anthony Michael D'urso is licensed to practice in Massachusetts (license number PH240019) and his current practice location is 121 Worcester Rd, Framingham, Massachusetts. He can be reached at his office (for appointments etc.) via phone at (508) 872-4265.

NPI number for Anthony Michael D'urso is 1003493974 and his current mailing address is 31 Lodge Rd, Newton, Massachusetts. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1003493974.

Contact Information

Anthony Michael D'urso,
121 Worcester Rd,
Framingham, MA 01701-5348
(508) 872-4265
Not Available

Healthcare Provider's Profile

Full NameAnthony Michael D'urso
GenderMale
SpecialityPharmacist
Location121 Worcester Rd, Framingham, Massachusetts
Accepts Medicare AssignmentsDoes not participate in Medicare Program. He may not accept medicare assignment.
  NPI Data:
  • NPI Number: 1003493974
  • Provider Enumeration Date: 03/26/2021
  • Last Update Date: 03/26/2021

Medical Identifiers

Medical identifiers for Anthony Michael D'urso such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1003493974NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
183500000XPharmacist PH240019 (Massachusetts)Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Anthony Michael D'urso is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Anthony Michael D'urso,
31 Lodge Rd,
Newton, MA 02465-1214

Ph: () -
Anthony Michael D'urso,
121 Worcester Rd,
Framingham, MA 01701-5348

Ph: (508) 872-4265

News Archive

Eli Lilly, Incyte announce collaboration for development and commercialization of INCB28050 oral inhibitor

Eli Lilly and Company and Incyte Corporation announced today that they have entered into an exclusive worldwide license and collaboration agreement for the development and commercialization of Incyte's oral JAK1/JAK2 inhibitor, INCB28050, and certain follow on compounds, for inflammatory and autoimmune diseases. The lead compound, INCB28050, is currently being studied in a six-month dose-ranging Phase II trial for rheumatoid arthritis.

Moderate exercise during pregnancy enhances newborn child's brain development

As little as 20 minutes of moderate exercise three times per week during pregnancy enhances the newborn child's brain development, according to researchers at the University of Montreal and its affiliated CHU Sainte-Justine children's hospital.

Radiation seed implant decreases risk of death over watchful waiting/active surveillance for prostate cancer

Prostate cancer patients cut their risk of dying of the disease in half when they receive radiation seed implants (brachytherapy) to treat their cancer, compared to those who don't receive active treatment (watchful waiting/active surveillance), within six months from being diagnosed with localized prostate cancer, according to a study presented October 31, 2007, at the American Society for Therapeutic Radiology and Oncology's 49th Annual Meeting in Los Angeles.

New vaccination method aims at comprehensive protection against all known influenza mutations

One shot, protected forever: This would be a dream come true regarding influenza vaccinations. So far, vaccination against influenza did not provide a lasting protection.

Researchers shed new light on identity of brain stem cells

The human nervous system is a complex structure that sends electrical signals from the brain to the rest of the body, enabling us to move and think. Unfortunately, when brain cells are damaged by trauma or disease they don't automatically regenerate. This can lead to permanent disability.

Read more News

› Verified 5 days ago


Pharmacist in Framingham, MA

Katie Schmidt, PHARM.D
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 776 Water St, Framingham, MA 01701
Phone: 508-877-2600    
Manhal Totonchy,
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 235 Old Connecticut Path, Framingham, MA 01701
Phone: 508-820-0903    
Purvi Patel, PHARMD
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 15 School St, Framingham, MA 01701
Phone: 508-788-0604    Fax: 508-788-3659
Karen Linnea Obarowski,
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 1280 Worcester Rd, Framingham, MA 01702
Phone: 339-221-1239    
John Michael Lavoie, PHARMD
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 1280 Worcester Rd, Framingham, MA 01702
Phone: 508-872-1432    
Sofiya Abraham,
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 4 Bishop St, 304, Framingham, MA 01702
Phone: 203-565-5205    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.